Skip to content
MarketScale
‹ Back to IndustriesHealthcare

TPC Cardiac Rhythm Management Initiative Saves Members Money and Improves Patient Outcomes

One of the main challenges for healthcare administrators is providing the best patient care possible while remaining profitable. They find themselves navigating ways to reduce costs and increase reimbursement, while simultaneously improving patient outcomes. Though the task can be daunting, many hospitals have found that strategic partnerships can provide the necessary support to help them…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

One of the main challenges for healthcare administrators is providing the best patient care possible while remaining profitable. They find themselves navigating ways to reduce costs and increase reimbursement, while simultaneously improving patient outcomes. Though the task can be daunting, many hospitals have found that strategic partnerships can provide the necessary support to help them achieve cost containment. TPC provides a platform that allows Members to work collaboratively to increase their financial, operational and clinical performance. One key method is through product standardization. As an example, TPC Members have seen significant success through product standardization in the purchase of cardiac rhythm management (CRM) devices and related products. Let’s take a closer look at how this program benefits healthcare organizations and patients.

The CRM contracting initiative engaged both TPC’s Cardiology Clinical Value Analysis Team (Cardio CVAT) and Cardiology Physician Sub-Committee (Cardio PSC). Our Members’ goal was to consolidate market share to a Member-selected vendor while also allowing, on an as-needed basis, access to other vendors currently in use. Prior to the initiative, Members were either on locally negotiated agreements or on national GPO agreements, with their collective spend in CRM spread across four separate vendors. This lack of aggregation created wide variations in product, price, and service across the membership.

When the Members decided to evaluate the opportunity in CRM, there were several challenges. First, many Members had pre-established relationships with vendors and felt they were being well serviced, making them reluctant to move market share to a new vendor. In addition, many physicians had brand loyalty to the products they used. This was, in large part, due to their depth of knowledge and comfort with the incumbent products. Finally, physicians were concerned about compliance requirements when contracting with a sole source supplier.

The CRM initiative was conceived as a Pre-Commit Program. TPC Members formally committed, prior to the launch of an initiative, to work together as a virtual system and move as a unit to the selected vendor upon the contract award. This commitment demonstrates to the marketplace, and to key stakeholders, the integrity of the TPC contracting process and the binding commitment the Members have to one another.

After a thorough evaluation by the Cardio CVAT and Cardio PSC, the Members selected a clinically acceptable product that provided the highest overall value, and thus consolidated their purchasing to one vendor. The result? Members have realized $3.45 million in total savings. As an added benefit, they achieved quality patient results via the innovative technology provided in the product selected. TPC Members have increased patient compliance to 97%, which has also led to increased reimbursement. This initiative was a success due to a high level of physician engagement, thought leadership, and peer discussion.

“When the CMR initiative was first brought to the Cardiology CVAT for consideration, there was much hesitation from the members – myself included. In the past, we had accomplished many successful initiatives, but none compared to this one. Working together alongside our physicians, we engaged in the evaluation process and made a selection we believed would provide the most value to the membership – and it has paid off significantly through the savings we have achieved. It is a true testament to what we can accomplish as a group when we put aside individual preferences and collaborate for the good of TPC as a whole,” explained Lisa Green, Director of Cardiology Services at United Regional Health Care System.

By working through a collaborative and committed model, TPC provides the framework for independent, community-based hospitals to achieve system value through standardization. TPC benefits both hospitals and patients—and provides significant cost savings. Stronger Together. Superior Results.

Read more at tpc1.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512